UFP Technologies

UFP Technologies

UFP Technologies went public in 1993 when CEO R. Jeffrey Bailly transformed a small foam packaging operation into a vertically integrated manufacturer. The firm operates from Newburyport, Massachusetts, and has always served as an operating company, not a portfolio manager — it generates revenue by moulding, laminating, and die-cutting advanced materials, rather than allocating third-party capital. The company deploys its balance sheet into production facilities and proprietary automation. Its products span three core categories: single-use sterile packaging for surgical kits, custom-engineered components embedded inside medical devices, and high-performance cases and inserts for defense electronics and semiconductor tooling. Confirmed end customers include Medtronic, Boston Scientific, and Intuitive Surgical (per the company's annual report, 2023). Its largest end market is medical, which accounts for roughly 85% of revenue, with the balance spread across aerospace and defense, automotive, and electronics. UFP operates more than a dozen manufacturing and design centers, predominantly in the United States, with additional capacity in Mexico and Costa Rica. Roughly 1,900 employees handle polymer chemistry, thermoforming, and cleanroom assembly under one corporate roof. In 2023 the firm completed the acquisition of AQF Medical (per company press release, October 2023), a deal that added advanced aqueous-based foam cleaning for orthopedic implants — a process explicitly required by several large orthopedic OEMs. The structural differentiator is verticality: UFP owns the design, tooling, and production under one roof. This gives medical-device customers a single chain of custody for sterile-barrier components, which shortens FDA validation cycles compared with multi-vendor supply chains. The firm is not a family office or allocator; it is a publicly listed manufacturer that competes with private converters like Prent Corporation and Sonoco's protective-solutions division.